Predictive clinical indicators of biochemical progression in advanced prostate cancer patients receiving Leuplin depot as androgen deprivation therapy.
Therapeutic planning and counseling for advanced prostate cancer patients receiving androgen deprivation therapy (ADT) is complicated because the prognoses are highly variable. The purpose of this study is to identify predictive clinical indicators of biochemical progression (BCP). In this retrospec...
Main Authors: | Chien-Hua Chen, Ju-Ton Hsieh, Kuo-How Huang, Yeong-Shiau Pu, Hong-Chiang Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4133301?pdf=render |
Similar Items
-
Using a half dose of leuplin depot in a long-term protocol for in vitro fertilization
by: Wen-Kao Tsai, et al.
Published: (2012-03-01) -
Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan
by: Kuang-Ming Liao, et al.
Published: (2019-12-01) -
Dose-finding study of Leuplin depot for prevention of premature luteinizing hormone surge during controlled ovarian stimulation: a pilot study in intrauterine insemination treatment
by: Heng-Ju Chen, et al.
Published: (2016-04-01) -
Risk of Comorbidities in Advanced Prostate Cancer Patients Receiving Androgen Deprivation Therapy
by: Olivia Rachel Hwang, et al.
Published: (2018) -
Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
by: Richard Shore, et al.
Published: (2021-06-01)